MIT Sues Shire Over Cell-Growing Mesh IP

Law360, New York (January 4, 2013, 6:24 PM EST) -- The Massachusetts Institute of Technology on Friday hit Shire PLC with a patent infringement suit in Massachusetts federal court, alleging that the drugmaker's Dermagraft treatment for diabetic foot ulcers uses a protected method of growing cells to replace damaged skin.

The university’s complaint centers on a patented polymer “scaffolding” that supports cell growth and is transferred into patients, where it helps patch wounds. According to MIT, Dermagraft uses cells that are derived from the foreskin of newborn babies and placed on a three-dimensional mesh scaffold, where...
To view the full article, register now.